Company / EPS (Diluted)
West Pharmaceutical Services EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$7.88
FY2025
5-year range
$3.21 / $8.67
FY2021-FY2025
Trend
+1.9%
vs FY2024
Sector context
#18 of 159
Health Care
What the data says
West Pharmaceutical Services's eps (diluted) of $7.88 is higher than 89% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $1.30 in FY2017 to $8.67 in FY2023.
Based on SEC 10-K filings.
7.88 in FY2025 with a 5-year CAGR of +23.5%. Top quartile in the Health Care sector.
Declined from $8.67 to $7.88 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +19.9%
- 5-Year CAGR
- +23.5%
- 10-Year CAGR
- -
Sector benchmark
+406.2% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 1.9% year-over-year.
- Ranks #18 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.88 | +1.9% |
| FY2024 | $7.73 | -10.8% |
| FY2023 | $8.67 | +89.7% |
| FY2022 | $4.57 | +42.4% |
| FY2021 | $3.21 | +17.2% |
| FY2020 | $2.74 | +37.7% |
| FY2019 | $1.99 | +4.2% |
| FY2018 | $1.91 | +46.9% |
| FY2017 | $1.30 | -25.7% |
| FY2016 | $1.75 | +11.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026